Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
A SWELL time to develop the molecular pharmacology of the volume-regulated anion channel (VRAC).
Channels (Austin). 2022 Dec;16(1):27-36. doi: 10.1080/19336950.2022.2033511.
Channels (Austin). 2022.
PMID: 35114895
Free PMC article.
Review.
We discuss the discovery and characterization of cysteinyl leukotriene receptor antagonists Pranlukast and Zafirlukast as novel VRAC inhibitors, and zinc pyrithione (ZPT), which apparently activates VRAC through a reactive oxygen species (ROS)-dependent mechanism. ...
We discuss the discovery and characterization of cysteinyl leukotriene receptor antagonists Pranlukast and Zafirlukast as novel VRAC …
Targeting amino acid metabolism of Mycobacterium tuberculosis for developing inhibitors to curtail its survival.
Yelamanchi SD, Surolia A.
Yelamanchi SD, et al.
IUBMB Life. 2021 Apr;73(4):643-658. doi: 10.1002/iub.2455. Epub 2021 Mar 5.
IUBMB Life. 2021.
PMID: 33624925
Free article.
Review.
Item in Clipboard
Cite
Cite